Reported Jun 28, 2017 · Terminated
Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and…
Lucid Pharma LLC
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Lucid Pharma LLC · 2 Tower Center Blvd · East Brunswick, NJ · 08816-1100
Is this the product you have?
- Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only
- Distributed by
Lucid Pharma LLC2 Tower Center BlvdSuite-1101-BEast BrunswickNJ 08816 USA
- Lot codes and dates
Lot #: a) V17516045-AExp 08/18b) V17516047-A 09/18
- Amount recalled
- a) 44168 bottles; b) 24960 bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Lucid Pharma LLC recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.